497 results
Page 2 of 25
8-K
qi2bldycy8ctvv
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
les2ybj4kmyihfh
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
425
m2o33h s0
2 Sep 22
Business combination disclosure
4:01pm
8-K
vj9kfy
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:33pm
425
hmi53n55cgawx
15 Aug 22
Business combination disclosure
6:46am
425
9wgs2p4ff 5q
10 Aug 22
Business combination disclosure
8:08am
8-K
EX-99.3
khvke
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.1
jl11bbvcgbihc5rcp
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
ohl21xwc vd5
29 Jul 22
Prospectus supplement
4:06pm
425
e8u2u4aptzahhbrceu
6 Jul 22
Business combination disclosure
4:05pm
425
qhg6fg0 cbk
9 Jun 22
Business combination disclosure
4:01pm
8-K
EX-99.2
t2t43ua emynh3
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
xi8o3m5s07cn 61
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-2.1
5pidmzkti72 juhy2ls
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am